Israel Research Finds Merck's Singulair Could Replace Tonsillectomies
This article was originally published in PharmAsia News
Israeli researchers said Merck's Singulair (montelukast) anti-inflammatory drug for treating asthma could replace tonsillectomies to resolve sleep-related respiratory disorders in some children.
You may also be interested in...
The US Senate on a 72-18 vote approved radiation oncologist Stephen Hahn as Commissioner of the FDA on 12 December. Voting “no” were a block of liberal Democrats, including the ranking member of a key Senate health committee. Industry advocates and most senators said Hahn is an excellent choice to lead the FDA, but some fear he will not move quickly enough to ban candy flavors in vaping products favored by teens.
The US FDA has qualified a new modeling tool that could give sponsors more assurance that their products meet the agency’s expectations for MRI-compatibility.